|Dear Seed Investor,
The next big run for marijuana is underway and one undervalued, fast-growing, 100% legal marijuana stock has three catalysts set to drive it much higher in the weeks ahead.
Following a hot IPO where the company raised more than $20 million to fund the rapid build-out of it’s world-class marijuana growth facility, ABcann Global (TSXV:ABCN/OTCBB:ABCCF) is poised to to go on another big run.
Here are three major catalysts set to propel ABcann to being the next big marijuana success story.
1. Invited To The “Blue Chip” Marijuana Stock Index
ABcann was just added to the Horizons Marijuana Life Sciences Index ETF (OTC:HMLSF) (TSX:HMMJ).
This is the world’s first marijuana ETF ever created.
The ETF holds the largest and most profitable marijuana companies in the world.
Among the ETF’s you’ll find marijuana biotech developer GW Pharmaceuticals (GWPH) and the world’s largest marijuana growers Canopy Growth and Aphria Inc.
All of those companies are worth more than $1 billion or more.
ABcann, at just 73 cents a share, is relatively tiny with a market value of only US$73 million.
That’s about to quickly change though because ABcann has been added to the Horizon’s ETF and as the assets of the marijuana ETF grows, it will be forced to buy more ABcann shares.
That’s just one driver behind the ABcann opportunity though.
2. 489% Growth Trajectory
ABcann is already in a strong position, but the real opportunity is in its expansion.
It already has a 14,500 square foot facility fully up and running and it’s producing some of the highest medical-grade marijuana in the world.
Now it’s in the process of completing a 71,000 square foot expansion project...a 489% increase over the current size of it’s production.
Best of all, the first harvest from the 71,000 square foot expansion just months away.
And when that first harvest comes in, this “small” marijuana company will be in league with the largest marijuana growing companies which are worth five to ten times more than ABcann is right now.
3. Major Financial Backing
Finally, and perhaps most impressively, ABcann just signed another MAJOR DEAL with Cannabis Wheaton (TSX.V:CBW).
The deal gives ABcann another $15 million to continues down its torrid growth path.
Here’s the kicker though...
Cannabis Wheaton had to buy into ABcann at C$2.25 (US$1.78) a share.
That’s a 144% premium over the current price you can buy ABcann right now.
Right now you can buy ABcann shares for US$0.73.
Some of the smartest, most experienced marijuana investors in the world just bought in at US$1.78.
No explanation needed.
Follow this link for all the details on this deal and how to play it for maximum gain.
Clearly ABcann Global (TSXV:ABCN / OTCBB:ABCCF) is positioned to be a big run.
It's one of Canada's strongest growers and is scaling up big time.
It just signed a major deal to fund new growth and production.
It has a strong well capitalized financial base and all the cash it needs to grow.
Yet it’s trading for less than $0.73 a share and has an overall market value of US$73 million, a fraction of many of its competitors.
If you’ve been looking for the next big marijuana winner, consider buying ABCann Global (TSXV:ABCN / OTCBB:ABCCF) before all of these catalysts hit.
The Seed Investor